Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3776694016 | Risankizumab | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3776695015 | Risankizumab (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
4357471000052117 | risankizumab | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Risankizumab | Is a | Substance with interleukin 23 receptor antagonist mechanism of action (substance) | true | Inferred relationship | Some | ||
Risankizumab | Has disposition (attribute) | Interleukin 23 receptor antagonist (disposition) | true | Inferred relationship | Some | ||
Risankizumab | Is a | murin-human monoklonal IgG-antikropp | false | Inferred relationship | Some | ||
Risankizumab | Is a | Immunosuppressant (substance) | true | Inferred relationship | Some | ||
Risankizumab | Is a | Monoclonal antibody | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Product containing risankizumab (medicinal product) | Has active ingredient | True | Risankizumab | Inferred relationship | Some | 1 |
Risankizumab-containing product in parenteral dose form | Has active ingredient | True | Risankizumab | Inferred relationship | Some | 1 |
Risankizumab only product in parenteral dose form | Has active ingredient | True | Risankizumab | Inferred relationship | Some | 1 |
Risankizumab only product | Has active ingredient | True | Risankizumab | Inferred relationship | Some | 1 |
This concept is not in any reference sets